Lv1
40 积分 2024-10-31 加入
Belzutifan plus cabozantinib for patients with advanced clear cell renal cell carcinoma previously treated with immunotherapy: an open-label, single-arm, phase 2 study
10小时前
待确认
Belzutifan plus cabozantinib as first-line treatment for patients with advanced clear-cell renal cell carcinoma (LITESPARK-003): an open-label, single-arm, phase 2 study
12小时前
已完结
Comprehensive analysis of MAPK genes in the prognosis, immune characteristics, and drug treatment of renal clear cell carcinoma using bioinformatic analysis and Mendelian randomization
18天前
已完结
Diagnostic and Prognostic Potential of FBXO8 Expression in Kidney Renal Clear Cell Carcinoma and Its Regulation of Renal Adenocarcinoma Cells
1个月前
已完结
Multifaceted role of NF-κB in hepatocellular carcinoma therapy: Molecular landscape, therapeutic compounds and nanomaterial approaches
2个月前
已完结
ATF family members as therapeutic targets in cancer: From mechanisms to pharmacological interventions
2个月前
已完结
Extracellular vesicles in cancer — implications for future improvements in cancer care
2个月前
已完结
Exosomes and their role in tumorigenesis and anticancer drug resistance
2个月前
已完结
New insights into antiangiogenic therapy resistance in cancer: Mechanisms and therapeutic aspects
2个月前
已完结
LncRNAs: the art of being influential without protein
2个月前
已完结
皖公网安备34019202002308
